ROL heads into its October earnings with short sellers rebuilding positions, analysts losing conviction, and options traders the least defensive they've been all year.
The most striking development this week is the speed of the short interest rebuild. Short interest jumped 14.5% over seven days to 3.6% of the free float — a sharp reversal from a month that had started softer. Looking at the history, shorts had been sitting near 12 million shares through late August, drifted down, then snapped back above 15 million in mid-September and hit 17.2 million by September 22. That's a rapid two-week accumulation. The borrow market remains wide open: availability is running at roughly 1,700% — seventeen shares available for every one already borrowed — so there is no mechanical squeeze risk here. Cost to borrow is negligible at 0.41%, even though that figure has doubled over the past month. The lending conditions are simply too loose to threaten anyone on the short side. Where the positioning story gets more interesting is in options. Calls are dominating activity. The put/call ratio has dropped to 0.47, nearly 1.6 standard deviations below its 20-day average of 0.62, and close to the lower end of the past year's range. Options traders are not hedging — they are reaching for upside in a stock that has fallen 11% over the past month.
That divergence between a rebuilding short book and call-heavy options flow captures the central tension in ROL right now. The Street is not resolving it helpfully. After Q2 results on July 23, analysts moved en masse to cut targets and several downgraded outright. JP Morgan and Bank of America both dropped the stock — JPM from Overweight to Neutral and BofA all the way from Buy to Underperform — with BofA setting a target of $35, barely above the current $32.86. Wells Fargo moved to Underweight with a $32 target, effectively saying fair value is here. The bulls who remain — Barclays and Piper Sandler both kept Overweight ratings — slashed targets to $45-$46 from the low $70s. That is a lot of wood to chop from today's price. The consensus is now firmly Hold, with nine analysts neutral against just four buyers, and no upgrades have appeared since the July earnings shock.
The valuation backdrop adds texture. ROL trades at 26x trailing earnings and an EV/EBITDA multiple near 17.4x. Both have compressed over the past 30 days as the stock sold off, but the absolute levels remain elevated for a business facing the headwinds analysts described after Q2 — slowing organic revenue growth, declining customer leads, and margin pressure. The factor scores reinforce the caution: EPS momentum trails badly, ranking in the 12th percentile over 90 days and the 35th over 30 days. Forward earnings estimate revisions are negative. The dividend score ranks near the top of the universe at the 98th percentile, but the dividend data in the snapshot is stale, so that figure should be treated cautiously.
The activist register adds a layer of structural context. The R. Randall Rollins Voting Trust holds a 33.3% stake via a Schedule 13D/A filed as recently as September 21. This is an activist-classified filing, though in practice it reflects the founding family's concentrated control rather than an external activist seeking board change. Positions are as-last-disclosed and the standard caveat applies — holders dropping below 5% may exit without a further filing. Among institutional holders, BlackRock and State Street both added shares in August, a modest counterweight to the broader selling pressure visible in the price. Qube Research built a new position of 3.2 million shares in Q2, a smaller but more active-manager-flavoured move worth noting.
The earnings history is the starkest data point in the pack. The July 23 print produced an 11.3% single-day decline and an 11.8% five-day loss. That was the last report, and the stock has not recovered. The next event is October 28. The setup into that date — short interest climbing, analysts with heavily reduced targets near or at the current price, call buyers pushing the PCR to a year-low — is the frame the market will be working with. Close peers RSG and WM both fell 4-4.4% on the week, suggesting broader sector softness rather than a ROL-specific story. Whether the October print can reverse the earnings-day trend, or validates the Wells Fargo and BofA bear case, is the watch point.
See the live data behind this article on ORTEX.
Open ROL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
